Omarali Iqbal I MD Pleasanton, CA - 94566

Omarali Iqbal I MD is categorized under Internal Medicine Practitioners in Pleasanton, CA and active since 2000.

Omarali Iqbal I MD was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Iqbal Omarali at the company’s single location by writing to 2324 Santa Rita Road # 11, Pleasanton, California CA 94566 or by phoning (925) 417-7505. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Omarali Iqbal I MD
Contact Person: Iqbal Omarali
Address: 2324 Santa Rita Road # 11, Pleasanton, California 94566
Phone Number: (925) 417-7505
Website Address: my-doctor.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Omarali Iqbal I MD was started in 2000 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Iqbal Omarali for inquiries that concern Omarali Iqbal I MD by calling the company number (925) 417-7505, as your correspondence is most welcome. Additionally, the physical location of the single location of Omarali Iqbal I MD can be found at the coordinates 37.68218,-121.87566 as well as the street address 2324 Santa Rita Road # 11 in Pleasanton, California 94566.

For its online presence, you may visit Omarali Iqbal I MD’s website at my-doctor.com and engage with its social media outlets through on Twitter and on Facebook.